Treatment modalities and medication recommended by health care professionals for treating recurrent herpes labialis

Journal of the American Dental Association

Volumn 135, Issue 1, 2004, Pages 48-54

  Raborn, G Wayne ^a   Chan, Karen S ^b   Grace, Michael ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOPURINE; ACICLOVIR; ANTIVIRUS AGENT; CETYLPYRIDINIUM SALT; CLOTRIMAZOLE; DRUG DERIVATIVE; DRUGS, NON PRESCRIPTION; FAMCICLOVIR; NON PRESCRIPTION DRUG; PENCICLOVIR; PRODRUG; VALACICLOVIR; VALINE;

ATTITUDE; CANADA; COMPARATIVE STUDY; CONTROLLED STUDY; DENTIST; DRUG COST; ECONOMICS; EMOTIONAL STRESS; FEMALE; GENERAL PRACTITIONER; HEALTH PRACTITIONER; HEALTH SURVEY; HERPES LABIALIS; HUMAN; MALE; MEDICAL ETHICS; MENTAL STRESS; OINTMENT; PAIN; PATIENT INFORMATION; PHARMACIST; POSTAL MAIL; PRESCRIPTION; RANDOMIZATION; RECURRENT DISEASE; REVIEW; TREATMENT INDICATION;

EID: 0942289841     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2004.0020     Document Type: Article

References (22)

1. Boon R, Bacon TH, Robey HL, et al. Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based survey. J Antimicrob Chemother 2000;46:324-5.
2. Lowhagen GB, Bonde E, Eriksson B, Nordin P, Tunback P, Krantz I. Self-reported herpes labialis in a Swedish population. Scand J Infect Dis 2002;34(9):664-7.
3. Axell T, Liedholm R. Occurrence of recurrent herpes labialis in an adult Swedish population. Acta Odontol Scand 1990;48(2):119-23.
4. Reichart PA. Oral mucosal lesions in a representative cross-sectional study of aging Germans. Community Dent Oral Epidemiol 2000;28(5):390-8.
5. Esmann J. The many challenges of facial herpes simplex virus infection. J Antimicrob Chemother 2001;47(supplement T1):17-27.
6. Evans TG, Bernstein DI, Raborn GW, Harmenberg J, Kowalski J, Spruance SL. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob Agents Chemother 2002;46(6):1870-4.
7. Spruance SL, Rowe NH, Raborn GW, Thibodeau EA, D'Ambrosio JA, Bernstein DI. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. J Infect Dis 1999;179(2):303-10.
8. Raborn GW, Martel AY, Grace MG, McGaw WT. Oral acyclovir in prevention of herpes labialis: a randomized, double-blind, multi-centered clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(1):55-9.
9. Raborn GW, Martel AY, Grace MG, McGaw WT. Herpes labialis in skiers: randomized clinical trial of acyclovir cream versus placebo. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84(6):641-5.
10. Raborn GW, McGaw WT, Grace M, Percy J, Samuels S. Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial. Oral Surg Oral Med Oral Pathol 1989;67(6):676-9.
11. Raborn GW, McGaw WT, Grace M, Houle L. Herpes labialis treatment with acyclovir 5 per cent ointment. J Can Dent Assoc 1989;55(2):135-7.
12. Raborn GW, McGaw WT, Grace M, Percy J. Treatment of herpes labialis with acyclovir: review of three clinical trials. Am J Med 1988;85(2A):39-42.
13. Raborn GW, McGaw WT, Grace M, Tyrrell LD, Samuels SM. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study. JADA 1987;115(1):38-42.
14. McGaw T, Raborn W, Grace M. Analgesics in pediatric dental surgery: relative efficacy of aluminum ibuprofen suspension and acetaminophen elixir. ASDC J Dent Child 1987;54(2):106-9.
15. Fink A. The survey kit. Thousand Oaks, Calif.: Sage; 1995:2-56.
16. Barclay S, Todd C, Finlay I, Grande G, Wyatt P. Not another questionnaire! Maximizing the response rate, predicting non-response, and assessing non-response bias in postal questionnaire studies of GPs. Fam Pract 2002;19(1):105-11.
17. Lamey PJ, Biagioni PA. Patient recognition of recrudescent herpes labialis: a clinical and virological assessment. J Dent 1996;24(5):325-7.
18. Bradley CP, Riaz A, Tobias RS, Kenkre JE, Dassu DY. Patient attitudes to over-the-counter drugs and possible professional responses to self-medication. Fam Pract 1998;15(1):44-50.
19. Raborn GW, Martel AY, Lassonde M, Lewis MAO, Boon R, Spruance SL. Worldwide Topical Penciclovir Collaborative Study Group. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. JADA 2002;133:303-9.
20. Tan RT, Burke FJT. Response rates to questionnaires mailed to dentists: a review of 77 publications. Int Dent J 1997;47:349-54.
21. Baqir W, Maguire A. Doctors' and pharmacists' attitudes to the use of sugar-free and sugar-containing medicines in the elderly. Int J Pharm Pract 2001;9(3):177-84.
22. Hindmarsh K. Optimal drug therapy: the role of the pharmacist in bridging the gap between knowledge and action. Can J Clin Pharmacol 2001;8(supplement A):53A-4A.